Flobow Wart Remover

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common warts characterized by a rough, cauliflower-like appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to follow the outlined procedure for the application of the medication to ensure optimal results.

The affected area should be washed thoroughly, and soaking in warm water for approximately 5 minutes may facilitate this process. After cleansing, the area must be dried completely to ensure proper adhesion of the medication.

A small amount of the medication should be applied directly to cover each wart. It is essential to allow the application to dry completely before proceeding with any further activities.

This application should be repeated twice daily as needed, with a maximum treatment duration of up to 12 weeks. Regular monitoring of the treatment area is recommended to assess the effectiveness and any potential side effects.

Contraindications

Use is contraindicated in the following situations:

Application on irritated or infected skin, or on areas exhibiting redness, is prohibited due to the potential for exacerbating the condition.

Patients with diabetes or poor blood circulation should not use this product, as it may pose an increased risk of complications.

Additionally, the product should not be applied to birthmarks, warts with hair growth, or moles, as these conditions may lead to adverse reactions.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is essential to rinse thoroughly with water for at least 15 minutes. Additionally, users should take precautions to avoid inhaling vapors associated with the product.

In cases of ingestion, immediate medical assistance should be sought. It is advisable to contact a Poison Control Center without delay if the product is swallowed.

Should any discomfort persist after use, it is crucial to discontinue use of the product and consult a healthcare professional for further evaluation and guidance.

Side Effects

Patients should be aware that the product is for external use only and must avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to rinse thoroughly with water for 15 minutes. Additionally, patients should take care to avoid inhaling vapors associated with the product.

If discomfort persists after application, patients are advised to stop use and consult a healthcare professional. This precaution is important to ensure safety and address any potential adverse reactions that may arise during use.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Flobow Wart Remover (salicylic acid 17% wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, healthcare providers should carefully evaluate the potential risks and benefits when considering treatment for lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure safety and therapeutic effectiveness.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that if the medication is swallowed, it is crucial to seek immediate medical assistance or contact a Poison Control Center. This action is essential to ensure the safety and well-being of the patient.

Additionally, healthcare providers should emphasize the importance of consulting a health professional before using this medication if the patient is pregnant or breastfeeding. This consultation is vital to assess potential risks and benefits associated with the use of the medication during these sensitive periods.

Storage and Handling

The product is supplied in a tube format, with specific handling and storage requirements to ensure its efficacy. It should be stored at room temperature, away from direct light exposure. To maintain product integrity, the tube must be kept tightly closed when not in use. Additionally, any unused product should be discarded after opening if it is not utilized within the recommended time frame.

Additional Clinical Information

The product is administered topically, with a recommended application of a small amount to cover each wart. Patients should allow the application to dry and may repeat this process twice daily as needed, for a maximum duration of 12 weeks.

Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Flobow Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)